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ABSTRACT
As a reversible post-translational modification
(PTM) discovered decades ago, protein lysine
acetylation was known for its regulation of tran-
scription through the modification of histones.
Recent studies discovered that lysine acetylation
targets broad substrates and especially plays an es-
sential role in cellular metabolic regulation.
Although acetylation is comparable with other
major PTMs such as phosphorylation, an integrated
resource still remains to be developed. In this work,
we presented the compendium of protein lysine
acetylation (CPLA) database for lysine acetylated
substrates with their sites. From the scientific litera-
ture, we manually collected 7151 experimentally
identified acetylation sites in 3311 targets. We stat-
istically studied the regulatory roles of lysine acetyl-
ation by analyzing the Gene Ontology (GO) and
InterPro annotations. Combined with protein–
protein interaction information, we systematically
discovered a potential human lysine acetylation
network (HLAN) among histone acetyltransferases
(HATs), substrates and histone deacetylases
(HDACs). In particular, there are 1862 triplet relation-
ships of HAT-substrate-HDAC retrieved from the
HLAN, at least 13 of which were previously experi-
mentally verified. The online services of CPLA
database was implemented in PHP+MySQL+
JavaScript, while the local packages were de-
veloped in JAVA 1.5 (J2SE 5.0). The CPLA database
is freely available for all users at: http://cpla
.biocuckoo.org.
INTRODUCTION
There are two types of acetylation processes widely
occurred in proteins (1–8). The ﬁrst N
a-terminal acetyl-
ation is catalyzed a variety of N-terminal acetyl-
transferases (NATs), which co-translationally transfer
acetyl moieties from acetyl-coenzyme A (Acetyl-CoA) to
the a-amino (N
a) group of protein amino-terminal
residues (1,2). Although N
a-terminal acetylation is rare
in prokaryotes, it was estimated that 85% of eukaryotic
proteins are N
a-terminally modiﬁed (1,2). The second type
is N
e-lysine acetylation, which speciﬁcally modiﬁes
e-amino group of protein lysine residues (3–8). Although
N
e-lysine acetylation is less common, it’s one of the most
important and ubiquitous post-translational modiﬁcations
(PTMs) conserved in prokaryotes and eukaryotes (1,2).
Moreover, the acetylation and deacetylation are dynamic-
ally and temporally regulated by histone acetyltransferases
(HATs) and histone deacetylases (HDACs), respectively
(4–8).
In 1964, Allfrey et al. (9) ﬁrst observed that lysine
acetylation of histones plays an essential role in regulation
of gene expression. Later and recent studies in epigenetics
solidiﬁed this seminal discovery, and proposed acetylation
as a key component of the ‘histone code’ (6). Beyond
histones, a wide-range of non-histone proteins can also
be lysine acetylated, and involved in a variety of biological
processes, such as transcription regulation (10), DNA rep-
lication (11), cellular signaling (12), stress response (13)
and so on. Aberrance of lysine acetylation and
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cancers (5,7,14). In particular, acetylation was
demonstrated to be implicated in cellular metabolism
and aging (15–17), while one class of NAD
+ dependent
HDACs of sirtuins might be potent drug target for
promoting longevity (13,17).
Although a great number of efforts have been carried
out during the past four decades, the functional contents
of lysine acetylation are still far from fully understood.
In this regard, identiﬁcation of acetylated substrates
with their sites is fundamental for understanding the mo-
lecular mechanisms and regulatory roles of acetylation.
In contrast with labor-intensive and time-consuming con-
ventional experimental approaches, recent progresses in
acetylome with high-throughput mass spectrometry (MS)
have detected thousands of acetylation sites. In 2006, Kim
et al. (14) performed a large-scale identiﬁcation of
acetylome with an anti-acetyllysine antibody. There were
195 acetylated proteins with 388 sites detected in HeLa
cells and mouse liver mitochondria (14). With a similar
strategy, Choudhary et al. (11) experimentally identiﬁed
3600 acetylation sites in human. In 2010, Zhao et al. (16)
discovered 1047 acetylated substrates in human liver,
and demonstrated acetylation playing a major role in
metabolic regulation. Furthermore, two acetylomic
studies revealed that the functions of lysine acetylation
are conserved in Escherichia coli (18) and Salmonella
enterica (15).
Since the number of known acetylation sites has rapidly
increased, it is an urgent topic to collect the experimental
data and provide an integrated resource for the commu-
nity. Recently, several public databases, such as
PhosphoSitePlus (19), HPRD (20), SysPTM (21) and
dbPTM (22), have already contained protein acetylation
information. In these databases, both of N
a-terminal and
N
e-lysine acetylation data were curated, while lysine
acetylation sites are usually only a limited part of total
sites. For example, SysPTM 1.1 contains 3001 acetylation
sites in 2000 proteins, with only 345 lysine sites (11.5%)
in 397 substrates (21). In dbPTM 2.0, 2071 experimentally
veriﬁed acetylation sites were collected in 1525 proteins,
with only 792 lysine sites (38.2%) in 299 targets (22).
Interestingly, HPRD release 9 contains 4691 total sites
in 1987 proteins, with 4420 lysine sites (94.2%) in 1821
substrates (20). However, HPRD database only focuses on
human protein information (20), while thousands of lysine
acetylation sites in other species still remain to be
collected.
With the motivation to meet the desire for complete
acetylomes, here we developed a novel database of com-
pendium of protein lysine acetylation (CPLA). From the
scientiﬁc literature in PubMed, we manually curated 3311
acetylated proteins with 7151 lysine sites (Table 1). In
CPLA database, the primary references and other
annotations of these substrates were provided, while the
protein–protein interaction (PPI) information was also
integrated. Based on the Gene Ontology (GO) and
InterPro annotations, we carried out an analysis of func-
tional diversities and regulatory roles of lysine acetylation.
As 75.64% of total lysine acetylation sites are taken from
Homo sapiens, a potential human lysine acetylation
network (HLAN) among HATs, substrates and HDACs
was constructed, with 1019 PPIs among 199 proteins.
Interestingly, we revealed 1862 potential triplet relation-
ships of HAT-substrate-HDAC, while at lease 13 were
previously experimentally veriﬁed. Taken together, the
CPLA database might be an integrated resource for
protein lysine acetylation and provide useful information
for further experimental or computational considerations.
CONSTRUCTION AND CONTENT
To ensure the quality of CPLA database, we searched the
PubMed with a major keyword ‘acetylation’ and collected
experimentally identiﬁed lysine acetylated proteins with
their sites from more than 18500 published articles
(before 1 March 2010). To avoid missing data, we
also search more articles with keywords ‘acetylated’ and
‘acetyl’. After all substrates with unambiguous acetylation
lysines were collected, we searched the UniProt
Knowledgebase (23) to obtain the corresponding protein
sequences and associated annotation information. The
theoretical pI (isoelectric point) and Mw (molecular
weight) were calculated for each protein (http://
www.expasy.org/tools/pi_tool.html) (24,25).
In CPLA database, the PPI information was also
integrated if available. We took experimental PPIs from
several major public databases (on 10 April 2010), such as
HPRD (20), BioGRID (26), DIP (27), MINT (28) and
IntAct (29). The redundant PPIs were thoroughly
cleared. In addition, a well-known pre-predicted
database of STRING (30) was also used. All proteins
were mapped to the UniProt sequences by BLAST. For
human, we collected a total of 59481 experimental PPIs
in 12221 proteins and 1212607 predicted PPIs in 16523
proteins, respectively. The detailed statistics of PPI infor-
mation was shown in Supplementary Table S1.
The CPLA 1.0 database contains 7151 lysine acetylation
sites in 3311 substrates (Table 1). Particularly, 1742
(24.4%) acetylation sites in 726 proteins are collected
from non-human species (Table 1). The online service
and local packages were implemented in PHP+
MySQL+JavaScript and JAVA 1.5 (J2SE 5.0), separate-
ly. Moreover, the online documentation and a user
manual were also provided.
Table 1. The data statistics of lysine acetylated proteins in CPLA
database
Organism Sub.
a Site
b Per.
c (%)
Homo sapiens 2585 5409 75.64
Salmonella typhimurium 190 260 3.64
Mus musculus 187 552 7.72
Escherichia coli 149 259 3.62
Saccharomyces cerevisiae 44 85 1.19
Others 156 586 8.20
Total 3311 7151 100
aSub., number of substrates;
bSite, number of acetylation sites;
cPer., percentiles of acetylation sites.
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The CPLA database 1.0 was developed in a user-friendly
manner. The search option (http://cpla.biocuckoo.org/
search.php) provides an interface for querying the CPLA
1.0 database with one or several keywords such as gene/
protein names, UniProt ID or CPLA ID, etc. For
example, if the keyword ‘STAT3’ is inputted and
submitted (Figure 1A), the result will be shown in a
tabular format, with the features of CPLA ID, UniProt
accession and protein/gene names/aliases (Figure 1B). By
clicking on the CPLA ID (CPLA-000136), the detailed
information for human STAT3 will be shown
(Figure 1C). The acetylation information, including
acetylated positions, ﬂanking peptides, experimental
reagents or upstream HATs, and primary references are
provided. The protein sequence, GO annotation, domain
organization, molecular weight, computed/ theoretical Ip
and PPI information are also presented.
Furthermore, we provided three additional advance
options, including (i) advance search, (ii) browse and
(iii) BLAST search (Supplementary Figure S1). (i)
Advance search: in this option, users could use relatively
complex and combined keywords to locate the precise in-
formation, with up to two search terms. The interface of
search-engine permits the querying by different database
ﬁelds and the linking of queries through three operators of
‘and’, ‘or’ and ‘exclude’ (Supplementary Figure S1A). (ii)
Browse: instead of searching for a speciﬁc protein, all
entries of CPLA database could be listed by species
name (Supplementary Figure S1B). (iii) BLAST search:
this option was designed for ﬁnding related information
in CPLA database quickly. The blastall program of NCBI
BLAST packages (31) was included in CPLA 1.0 database
(Supplementary Figure S1C). Users can input a protein
sequence in FASTA format for searching identical or
homologous proteins.
Figure 1. The search option of CPLA 1.0 database. (A) Users could simply input ‘STAT3’ for querying. (B) The results will be shown in a tabular
format. Users could click on the CPLA ID (CPLA-000025) to visualize the detailed information. (C) The detailed information of human STAT3. The
PPI information was also presented.
Nucleic AcidsResearch, 2011,Vol. 39, Database issue D1031RESULTS AND DISCUSSION
Recent progresses toward understanding the full function-
al content of acetylome have experimentally revealed
several thousands of lysine acetylated substrates with
their sites. Besides experimental efforts, computational
studies such as predictor construction and database devel-
opment also attract much attention. The current available
computational resources were summarized and listed in
Supplementary Table S2. Among these researches,
database development is particularly important for
integrating experimental data from heterogeneous
sources, and providing a high quality benchmark for
further experimental or computational designs. Although
several public databases (19–22) have already maintained
the acetylation information, the lysine acetylation is
usually collected together with another less controlled
N
a-terminal acetylation. In this work, we only focused
on protein lysine acetylation and manually curated 7151
lysine acetylation sites in 3311 proteins.
Since a large proportion of acetylation sites were taken
from Homo sapiens, we had the opportunity to analyze
abundance and functional diversity of lysine acetylation
in an acetylomic level. We surveyed the GO terms of 2585
acetylated proteins from UniProt annotations. Using the
human proteome as the background, we statistically
calculated over-represented biological processes, molecu-
lar functions and cellular components in acetylome with
the hypergeometric distribution (P<0.01). The top ﬁve
most enriched GO entries in each category were shown
in Table 2. Our analyses revealed several potentially inter-
esting results. For example, the three most abundant bio-
logical processes such as translational elongation, RNA
splicing and mRNA processing suggest that acetylation
predominantly regulates gene expression in a post-
transcriptional manner (Table 2). Also, four most
over-represented molecular functions such as ATP
binding, protein binding, RNA binding and nucleotide
binding suggest that acetylation modulates enzyme
activity and protein interaction ability (Table 2). In
addition, the statistical analysis of cellular components
revealed acetylated proteins to be highly enriched in
distinct cellular compartments. For instance, 30 and
62% of cytosol and mitochondrial matrix proteins are
acetylated, respectively (Table 2). For more detailed infor-
mation, the top 15 most over-represented GO terms
and InterPro domains were shown in Supplementary
Tables S3 and S4.
The acetylation and deacetylation of proteins are carried
out by HATs and HDACs, which antagonistically and dy-
namically control protein function. Combined with experi-
mental and predicted PPIs, we constructed a potential
HLAN among HATs, substrates and HDACs, with 1019
PPIs of 199 proteins (Supplementary Table S5). If only
experimental PPIs are considered, the core HLAN con-
tained 369 PPIs among 77 proteins, including 12 HATs
and 12 HDACs (Figure 2). From the whole HLAN, we
retrieved 1862 potential triplet relations of HAT–sub-
strate–HDAC (Supplementary Table S6). If a substrate is
a HAT or HDAC, it should be acetylated or deacetylated
by a different HAT or HDAC. We carefully surveyed sci-
entiﬁc literature and found that at least 13 triplet inter-
actions were experimentally identiﬁed (Supplementary
Table S6). For example, Gaughan et al. (32) observed
that Tip60 (KAT5) and histone deacetylase 1 (HDAC1)
regulate the transcriptional activity of androgen receptor
(AR) through changing its acetylation status, and form a
KAT5-AR-HDAC1 relation (Supplementary Table S6).
Moreover, our results also discovered a number of poten-
tially interesting results. For instance, EP300 acetylates
BCL6 at K379 and inhibits its function, while deacetylases
were not clearly identiﬁed (33). In our results, the
EP300-BCL6-HDAC5, EP300-BCL6-SIRT2, EP300-
BCL6-HDAC11, EP300-BCL6-HDAC3, EP300-BCL6-
HDAC2 and EP300-BCL6-HDAC8 suggested that BCL6
Table 2. The top ﬁve most enriched GO terms of biological processes, molecular functions and cellular components in human acetylome
Description of GO term Acetylome Proteome E-ratio
c P-value
n (%)
a,b n (%)
The top ﬁve most enriched biological processes
Translational elongation (GO:0006414) 69 (2.80) 93 (0.52) 5.44 3.35E-40
Nucleosome assembly (GO:0006334) 43 (1.75) 79 (0.44) 3.99 1.17E-17
RNA splicing (GO:0008380) 70 (2.84) 188 (1.04) 2.73 3.50E-16
Interspecies interaction between organisms (GO:0044419) 100 (4.06) 333 (1.85) 2.20 3.97E-15
mRNA processing (GO:0006397) 65 (2.64) 193 (1.07) 2.47 9.06E-13
The top ﬁve most enriched molecular functions
ATP binding (GO:0005524) 398 (16.17) 1473 (8.17) 1.98 4.67E-46
Protein binding (GO:0005515) 798 (32.06) 3996 (22.16) 1.45 9.00E-35
RNA binding (GO:0003723) 186 (7.56) 557 (3.09) 2.45 9.49E-34
Structural constituent of ribosome (GO:0003735) 71 (2.89) 155 (0.86) 3.36 1.99E-22
Nucleotide binding (GO:0000166) 85 (3.45) 255 (1.41) 2.44 5.75E-16
The top ﬁve most enriched cellular components
Cytosol (GO:0005829) 298 (12.11) 1009 (5.60) 2.16 4.71E-42
Mitochondrial matrix (GO:0005759) 83 (3.37) 139 (0.77) 4.38 6.33E-37
Nucleoplasm (GO:0005654) 124 (5.04) 333 (1.85) 2.73 1.12E-27
Nucleolus (GO:0005730) 133 (5.40) 425 (2.36) 2.29 1.84E-21
Cytosolic small ribosomal subunit (GO:0022627) 29 (1.18) 36 (0.20) 5.90 2.24E-19
aNum., number of proteins annotated;
bPer. percentiles of proteins annotated;
cE-ratio, enrichment ratio of acetylated proteins.
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Table S6). Moreover, human GCMa/GCM1 was reported
to be acetylated by CBP/CREBBP at K367, K406 and
K409 (34). In our results, the relations of CREBBP-
GCM1-HDAC3, CREBBP-GCM1-HDAC3, CREBBP-
GCM1-HDAC1 and CREBBP-GCM1-HDAC4
proposed that at least four HDACs might deacetylate
GCM1 (Supplementary Table S6).
Taken together, here we developed a comprehensive
database of protein lysine acetylation. The statistical
analyses revealed functional diversity and enrichment of
acetylation, while network studies generated a large
number of potentially useful results for further experimen-
tal or computational researches. The CPLA database will
be routinely updated if new acetylated substrates are
reported.
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